A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Mereo Biopharma Group Plc ADR’s current trading price is -8.76% away from its 52-week high, while its distance from the 52-week low is 328.04%. The stock’s price range for this time frame has been between $1.07 and $5.02. The trading volume of the company’s shares in the Healthcare reached around 0.71 million for the day, which was evidently lower than the average daily volume of 1.16 million over the last three months.
The market performance of Mereo Biopharma Group Plc ADR has been somewhat stable.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Mereo Biopharma Group Plc ADR (MREO) has experienced a quarterly rise of 27.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 704.22M and boasts a workforce of 33 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How MREO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MREO stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.01.
MREO Stock Stochastic Average
MREO Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 98.27% this year. Over the last six months, there has been a weaker performance of 20.53%. The price of MREO fallen by 12.81% during the last 30 days period. For the last 5-days stocks have improved 1.55%.
